| Opioid-induced respiratory depression: reversal by non-opioid drugs R Van Der Schier, M Roozekrans, M Van Velzen, A Dahan, M Niesters F1000prime reports 6, 2014 | 124 | 2014 |
| Averting opioid-induced respiratory depression without affecting analgesia A Dahan, R van der Schrier, T Smith, L Aarts, M van Velzen, M Niesters Anesthesiology 128 (5), 1027-1037, 2018 | 111 | 2018 |
| Opioid-induced respiratory depression in humans: a review of pharmacokinetic–pharmacodynamic modelling of reversal MH Algera, J Kamp, R van der Schrier, M van Velzen, M Niesters, L Aarts, ... British Journal of Anaesthesia 122 (6), e168-e179, 2019 | 96 | 2019 |
| Opioid-induced respiratory depression in the acute care setting: a compendium of case reports F Overdyk, A Dahan, M Roozekrans, R der Schrier, L Aarts, M Niesters Pain management 4 (4), 317-325, 2014 | 80 | 2014 |
| Influence of ethanol on oxycodone-induced respiratory depression: a dose-escalating study in young and elderly individuals R van der Schrier, M Roozekrans, E Olofsen, L Aarts, M van Velzen, ... Anesthesiology 126 (3), 534-542, 2017 | 58 | 2017 |
| Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers M Roozekrans, R van der Schrier, P Okkerse, J Hay, JF McLeod, A Dahan Anesthesiology 121 (3), 459-468, 2014 | 49 | 2014 |
| Reversal of opioid‐induced respiratory depression by BK‐channel blocker GAL021: A pharmacokinetic‐pharmacodynamic modeling study in healthy volunteers M Roozekrans, E Olofsen, R Van Der Schrier, J Van Gerven, S Peng, ... Clinical Pharmacology & Therapeutics 97 (6), 641-649, 2015 | 41 | 2015 |
| An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers R Van der Schrier, K Jonkman, M Van Velzen, E Olofsen, AM Drewes, ... BJA: British Journal of Anaesthesia 119 (6), 1169-1177, 2017 | 40 | 2017 |
| Benefit versus Severe Side Effects of Opioid Analgesia: Novel Utility Functions of Probability of Analgesia and Respiratory Depression M Roozekrans, R van der Schrier, L Aarts, E Sarton, M van Velzen, ... Anesthesiology 128 (5), 932-942, 2018 | 28 | 2018 |
| Differential role of nitric oxide in the psychedelic symptoms induced by racemic ketamine and esketamine in human volunteers K Jonkman, R Van Der Schrier, M Van Velzen, L Aarts, E Olofsen, ... British Journal of Anaesthesia 120 (5), 1009-1018, 2018 | 19 | 2018 |
| Effect of paroxetine or quetiapine combined with oxycodone vs oxycodone alone on ventilation during hypercapnia: a randomized clinical trial J Florian, R van der Schrier, V Gershuny, MC Davis, C Wang, X Han, ... Jama 328 (14), 1405-1414, 2022 | 14 | 2022 |
| Opioid overdose: limitations in naloxone reversal of respiratory depression and prevention of cardiac arrest M van Lemmen, J Florian, Z Li, M van Velzen, E van Dorp, M Niesters, ... Anesthesiology 139 (3), 342-353, 2023 | 13 | 2023 |
| Advances in reversal strategies of opioid-induced respiratory toxicity R van der Schrier, JDC Dahan, M Boon, E Sarton, M van Velzen, ... Anesthesiology 136 (4), 618-632, 2022 | 12 | 2022 |
| Buprenorphine: a treatment and cause of opioid-induced respiratory depression A Dahan, M van Lemmen, S Jansen, P Simons, R van der Schrier British Journal of Anaesthesia 128 (3), 402-404, 2022 | 10 | 2022 |
| Doxapram‐mediated Increase in Cardiac Output Reduces Opioid Plasma Concentrations: A Pharmacokinetic/Pharmacodynamic–Pharmacokinetic/Pharmacodynamic Modeling Study in Healthy … M Roozekrans, E Olofsen, R van der Schrier, M Boom, R Mooren, ... Clinical Pharmacology & Therapeutics 102 (1), 115-122, 2017 | 10 | 2017 |
| Carbon dioxide tolerability and toxicity in rat and man: a translational study R van der Schrier, M van Velzen, M Roozekrans, E Sarton, E Olofsen, ... Frontiers in Toxicology 4, 1001709, 2022 | 8 | 2022 |
| Respiratory effects of the atypical tricyclic antidepressant tianeptine in human models of opioid-induced respiratory depression H Algera, R van der Schrier, D Cavalla, M van Velzen, M Roozekrans, ... Anesthesiology 137 (4), 446-458, 2022 | 8 | 2022 |
| Doxapram reduces alfentanil plasma concentrations associated with an increase in cardiac output M Roozekrans, R van der Schrier, P Hoskins, J Mc Cleod, A Dahan Annual Meeting of the American Society of Anesthesiologists, A3165, 2013 | 8 | 2013 |
| Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic–Pharmacodynamic Comparison with Morphine P Simons, R van der Schrier, M van Lemmen, S Jansen, KWK Kuijpers, ... Anesthesiology 138 (3), 249-263, 2023 | 7 | 2023 |
| Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations: a PK-PD/PK-PD modeling study in healthy volunteers M Roozekrans, E Olofsen, R van der Schrier, M Boom, R Mooren, ... Clin Pharmacol Ther 102 (1), 115-122, 2017 | 7 | 2017 |
